The rising interest in potent weight management has led to considerable investigation into groundbreaking treatments. Recently , Retatrutide, a combined -action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has demonstrated positive results in clinical trials, implying potential for significant weight reduction . Therefore, numerous